What Is LH Fair Value?
Labcorp (LH) fair value estimate using multiple valuation models, updated daily.
As of July 16, 2026, Labcorp (LH) has a composite fair value estimate of $228.16 based on four valuation models: DCF (35% weight), Graham Number (25% weight), PEG (25% weight), and DDM (15% weight). The current market price is $271.99, suggesting the stock is overvalued by 16.1%.
Data as of July 16, 2026 (today)
Composite Fair Value
Overvalued4 of 4 models$228.16
vs. current price of $271.99(-16.1%)
How Is LH Fair Value Calculated?
Four independent models estimate what LH is worth. Each uses different inputs and assumptions. The composite blends them by weight.
LH Intrinsic Value
Forward-looking models based on future cash flows
DCF (Discounted Cash Flow)
35% weightEstimates how much cash the company will generate over the next 10 years, then calculates what all that future cash is worth in today's dollars. Includes a 15% safety cushion. Try the standalone DCF calculator →
$296.57
+9.0%Fair Value
Inputs used
DDM (Dividend Discount Model)
15% weightIf a company pays you dividends, this model asks: how much are all those future dividend payments worth today? Only works for stocks that pay dividends. Try the intrinsic value calculator →
$61.28
-77.5%Overvalued
Inputs used
LH Fair Value
Current fundamentals: earnings, assets, and growth rate
Graham Number (Value Investing)
25% weightCreated by legendary investor Benjamin Graham. It looks at two things: how much the company earns (EPS) and what its assets are worth (Book Value), then calculates the maximum price a careful investor should pay. Try the fair value calculator →
$207.31
-23.8%Overvalued
Inputs used
PEG (Price/Earnings to Growth)
25% weightChecks if you're paying a fair price for the company's growth. A fast-growing company deserves a higher price than a slow one. This model finds the right price based on how fast earnings are growing.
$180.10
-33.8%Overvalued
Inputs used
What If You Change the Assumptions?
Drag the sliders to test different scenarios. Tap the ? buttons to learn what each input means.
Your DCF Fair Value
Current price $271.99 is 9.0% below this estimate
View 10-year cash flow projections
| Year | Projected FCF (Free Cash Flow) | Present Value |
|---|---|---|
| Year 1 | $1.24B | $1.15B |
| Year 2 | $1.35B | $1.16B |
| Year 3 | $1.47B | $1.17B |
| Year 4 | $1.59B | $1.17B |
| Year 5 | $1.73B | $1.18B |
| Year 6 | $1.88B | $1.19B |
| Year 7 | $2.04B | $1.20B |
| Year 8 | $2.22B | $1.21B |
| Year 9 | $2.41B | $1.21B |
| Year 10 | $2.62B | $1.22B |
| Terminal Value | $49.48B | $23.06B |
What Are LH's Key Financial Metrics?
Earnings & Growth
Current Price
$271.99
EPS (TTM)
$11.15
Forward P/E
14.0
Profit Margin
6.7%
Cash & Balance Sheet
Free Cash Flow
1.1B
EBITDA
2.3B
Book Value
$106.06
Total Debt
7.3B
What Do Analysts Say About LH?
Low
$270.00
Average
$312.35
High
$340.00
Upside
+14.8%
LH Fair Value FAQ
What is the fair value of LH?
Based on our composite model (DCF 35%, Graham 25%, PEG 25%, DDM 15%), LH's estimated fair value is $228.16. The stock is currently trading at $271.99, which makes it overvalued by our analysis.
How is LH's fair value calculated?
We use four valuation methods: Discounted Cash Flow (DCF), Graham Number, PEG-based Fair Value, and Dividend Discount Model (for dividend-paying stocks). The composite score weights DCF at 35%, Graham and PEG at 25% each, and DDM at 15%. When a model can't be applied, its weight is redistributed proportionally.
Is LH overvalued or undervalued?
Based on our analysis, LH is overvalued. The current price of $271.99 is 16.1% above our estimated fair value of $228.16.
What do Wall Street analysts say about LH?
17 analysts cover Labcorp with a consensus rating of "Buy." The average price target is $312.35, ranging from $270.00 to $340.00. This implies 14.8% upside from the current price.